---
topic: "pantothenic-acid"
period: "2026-02"
generated_at: "2026-02-24T20:08:20.479164+00:00"
total_articles: 473
---

# 泛酸文獻薈萃報告 — 2026 年 2 月

## 摘要

本月共收錄 泛酸 相關文獻 473 篇，其中 Level 1 證據（Meta-Analysis/Systematic Review）10 篇，RCT 2 篇。

## 證據等級分布

| 證據等級 | 文獻數 | 佔比 |
|----------|--------|------|
| Level 1 (Meta-Analysis/Systematic Review) | 10 | 2.1% |
| Level 2 (RCT) | 2 | 0.4% |
| Level 3 (Clinical Trial) | 0 | 0.0% |
| Level 4 (Observational) | 3 | 0.6% |
| Level 5 (Review/Case Report/Other) | 458 | 96.8% |

## 功效分類統計

| 功效分類 | 中文 | 文獻數 | 佔比 |
|----------|------|--------|------|
| other | 其他 | 234 | 49.5% |
| metabolic | 代謝 | 94 | 19.9% |
| immune | 免疫調節 | 70 | 14.8% |
| cardiovascular | 心血管 | 52 | 11.0% |
| digestive | 消化 | 40 | 8.5% |
| anti_aging | 抗衰老 | 32 | 6.8% |
| cognitive | 認知功能 | 30 | 6.3% |
| musculoskeletal | 肌肉骨骼 | 29 | 6.1% |
| energy | 活力 | 25 | 5.3% |
| skin | 皮膚 | 15 | 3.2% |
| sexual | 性功能 | 10 | 2.1% |

## 成分搭配統計

| 成分 | 文獻數 |
|------|--------|
| EPA | 62 |
| iron | 61 |
| calcium | 16 |
| vitamin D | 14 |
| vitamin C | 13 |
| glutathione | 12 |
| NAC | 12 |
| folate | 11 |
| selenium | 9 |
| folic acid | 7 |

## 成分組合分析

以下列出最常被共同研究的成分組合：

| 成分組合 | 共同出現文獻數 |
|----------|---------------|
| EPA + iron | 10 |
| glutathione + iron | 4 |
| calcium + iron | 4 |
| EPA + NAC | 4 |
| iron + zinc | 4 |
| selenium + zinc | 3 |
| vitamin C + vitamin E | 3 |
| folate + iron | 3 |
| folate + vitamin A | 3 |
| folate + vitamin B6 | 3 |

## 成分功效分析

以下列出主要成分在各功效領域的研究文獻數：

| 成分 | 總文獻 | 其他 | 代謝 | 心血管 | 免疫調節 | 消化 | 認知功能 |
|------|--------|--------|--------|--------|--------|--------|--------|
| EPA | 62 | 27 | 16 | 10 | 11 | 9 | 3 |
| iron | 61 | 27 | 10 | 10 | 12 | 9 | - |
| calcium | 16 | 6 | 4 | 2 | 3 | - | 3 |
| vitamin D | 14 | 3 | 8 | 4 | 2 | 1 | 2 |
| vitamin C | 13 | 5 | 3 | 3 | 3 | 1 | 3 |
| glutathione | 12 | 1 | 4 | 5 | 4 | 1 | 2 |
| NAC | 12 | 7 | 2 | 2 | 2 | 2 | 1 |
| folate | 11 | 3 | 6 | 2 | - | - | 2 |

## 研究類型分布

| 研究類型 | 文獻數 | 佔比 |
|----------|--------|------|
| Meta-Analysis | 3 | 0.6% |
| Systematic Review | 7 | 1.5% |
| RCT | 2 | 0.4% |
| Clinical Trial | 0 | 0.0% |
| Observational | 3 | 0.6% |
| Review | 16 | 3.4% |
| Case Report | 17 | 3.6% |
| Other | 425 | 89.9% |

## 近期重要文獻

### Level 1 證據（Meta-Analysis / Systematic Review）

1. **[Behçet's Disease In Children And Adults Of Sub-Saharan Ancestry: A Systematic Review And Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/40810771/)** — Clinical reviews in allergy & immunology, 2025-08-14
   - 功效分類：cognitive

2. **[Revealing VNN1: An Emerging and Promising Target for Inflammation and Redox Balance.](https://pubmed.ncbi.nlm.nih.gov/41090263/)** — Immunity, inflammation and disease, 2025-10-01
   - 功效分類：immune, metabolic

3. **[Effects of tetrahydroindenoindole supplementation on metabolism: A systematic review with meta-analysis of rodent-based studies.](https://pubmed.ncbi.nlm.nih.gov/40323488/)** — GeroScience, 2025-05-05
   - 功效分類：metabolic

4. **[Systematic review of innate immune responses against](https://pubmed.ncbi.nlm.nih.gov/39949719/)** — Frontiers in immunology, 2024-01-01
   - 功效分類：immune

5. **[Pantothenic Acid and Parkinson Disease: A Systematic Review of Metabolomics Analysis Studies.](https://pubmed.ncbi.nlm.nih.gov/41712554/)** — Nutrition reviews, 2026-02-19
   - 功效分類：cognitive


### Level 2 證據（RCT）

1. **[Implementation of the Study Participant Feedback Questionnaire to understand participant experience in a phase 3 oncology clinical trial.](https://pubmed.ncbi.nlm.nih.gov/41151963/)** — BMJ open, 2025-10-28
   - 功效分類：other

2. **[Safety, Pharmacokinetics, and Pharmacodynamics of BI 1595043, a Selective Vanin Inhibitor, in Phase 1 Clinical Trials Involving Healthy Volunteers.](https://pubmed.ncbi.nlm.nih.gov/40952900/)** — Clinical and translational science, 2025-09-01
   - 功效分類：immune

